T 1407/22 (CLD18A2 targeting CAR T-cells/CRAGE) of 23.04.2024
- European Case Law Identifier
- ECLI:EP:BA:2024:T140722.20240423
- Date of decision
- 23 April 2024
- Case number
- T 1407/22
- Online on
- 25 April 2024
- Petition for review of
- -
- Application number
- 15821331.4
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Immunologic effector cell of targeted CLD18A2, and preparation method and use thereof
- Applicant name
- CRAGE medical Co., Limited
- Opponent name
- BioNTech Cell & Gene Therapies GmbH
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 113(2) 1973
- Keywords
- Basis of decision - agreement to text of the patent as granted withdrawn by patent proprietor
Basis of decision - patent revoked - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.